When assessing the value of a reward, people with schizophrenia have difficulty integrating information about the size of the reward and the probability of receiving it, according to a published study.
Schizophrenia & Psychotic Disorders
Vast individual differences in brain structure make the concept of “the average patient with schizophrenia” practically meaningless, suggests a study published online in JAMA Psychiatry.
New guidelines from the European Psychiatric Association promote exercise as a core part of treatment for severe mental illnesses, including major depressive disorder and schizophrenia.
Schizophrenia is a neurodevelopmental, rather than a neurodegenerative disorder, meaning cognitive control deficits are present at onset and not the result of brain deterioration, a new study suggests.
MRI-based predictive tools could inform therapeutic decision making, potentially preventing functional impairment in patients at high clinical risk of psychosis and those with recent-onset depression, researchers say.
Intra-Cellular Therapies, Inc. has submitted a New Drug Application to the US Food and Drug Administration for lumateperone, a investigational medicine with a novel mechanism of action for the treatment of schizophrenia.